HEALTH
IL-33 Targeting Shows Promise in COPD Treatment, Questions Remain
Recent studies suggest that targeting IL-33 can significantly reduce COPD exacerbations, but the effectiveness across various patient profiles is still unclear.
Recent studies suggest that targeting IL-33 can significantly reduce COPD exacerbations, but the effectiveness across various patient profiles is still unclear.
Research demonstrates that combining hydroxyurea with blood transfusions can reduce treatment burdens in severe sickle cell disease patients.
Recent findings assess how endovascular thrombectomy performs in clinical practice for patients with large ischemic strokes.
Infective endocarditis occurred in 2.63% of TAVR patients versus 5.37% after SAVR, suggesting a lower risk with TAVR.
Udaipur, July 18: A one-day national conference on Nuclear Medicine and Prostate Cancer was organised at the American International Institute of Medical…